Mayo Clinic Laboratories > International > Global capabilities

Global capabilities

Delivering value beyond the test result

At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.

70+

70+ countries connected to Mayo Clinic Laboratories

99%

99% system uptime

50,000+

50,000+ specimens arrive daily at Mayo Clinic Laboratories

97%+

97%+ of shipments arrive on time

Specialized testing areas include:

Cardiology Cardiology
Cardiology

Featuring more than 160 assays, our cardiovascular testing menu offers care-driven testing approaches that provide definitive results.

Endocrinology Endocrinology
Endocrinology

The Endocrine Laboratory at Mayo Clinic is one of the leading endocrine testing facilities in the United States and has developed more than 70 common and esoteric assays to help clarify endocrine function.

Gastroenterology Gastroenterology
Gastroenterology

Developed in collaboration with the clinical gastroenterology practice at Mayo Clinic, our full suite of patient-focused gastrointestinal and hepatology evaluations includes testing for rare and common illnesses.

Genetics Genetics
Genetics

Encompassing exploratory testing, hereditary testing, prenatal testing, pharmacogenomic testing, and more, our genetic testing was developed by teams of experienced geneticists, genetic counselors, laboratory scientists, and bioinformaticians and uses advanced molecular and biochemical testing techniques to detect variants related to inherited illness.

Hematology Hematology
Hematology

Our hematology test menu includes more than 30 algorithms that can help simplify the ordering process, increase efficiency, reduce costs, and improve patient care.

Infectious diseases Infectious diseases
Infectious diseases

Developed by a team of clinical microbiology experts, our comprehensive infectious disease testing utilizes a broad range of methodologies to identify and characterize causative agents of bacterial, viral, and fungal infections.

Neurology Neurology
Neurology

Our neurology testing covers the full range of specialties, including autoimmune disorders, dementia, multiple sclerosis, neurogenetics, and pediatric disorders. Collaboration between our labs and the clinical practice at Mayo Clinic supports the development of clinically validated, actionable testing.

Newborn screening Newborn screening
Newborn screening

Our confirmatory, second-tier newborn screening testing employs more sensitive methodologies and is performed on the original newborn screening specimen when the primary screening assay yields abnormal results.

Oncology Oncology
Oncology

Our robust oncology menu covers the spectrum of oncological specialties and includes MayoComplete next-generation sequencing solid tumor testing, hereditary cancer testing, and testing for pediatric illness.

Pathology Pathology
Pathology

More than 100 pathologists working in 19 subspecialized groups provide more than 45,000 second-opinion consultations each year, delivering unparalleled expertise on every type and stage of cancer.

Pediatrics Pediatrics
Pediatrics

Featuring more than 2,000 assays, many with pediatric reference ranges, our pediatric testing is supported by more than 150 years of clinical experience and access to more than 4,500 Mayo Clinic physicians and scientists.

Prenatal Prenatal
Prenatal

We offer a full suite of prenatal evaluations, including diagnostic and companion testing, carrier screening, and pregnancy loss/loss of conception testing. Our testing experts provide ordering guidance and result interpretation of the highest quality for prenatal diagnosis of genetic conditions.

Renal Renal
Renal

Including glomerular disease testing, kidney function testing, genetic testing, renal pathology, and urinary stone services, our renal evaluations are supported by more than 150 years of clinical experience treating renal disease.

Therapeutics Therapeutics
Therapeutics

Our specialized therapeutics test menu features more than 190 tests to help clinicians guide patient care across the full range of areas, including addiction rehabilitation, pain management, and precision therapeutics.

Global logistics and shipping

We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.

These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.

Optimized, expeditious processing

We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:  

  • Running tests continuously – your samples are processed alongside those from Mayo Clinic.
  • A testing approach that incorporates comprehensive panels and algorithms when appropriate.
  • Utilization of Lean and Six Sigma processes.

Reliable connectivity

We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:

  • Client-friendly test ordering through MayoLINK, which is available in eight languages.
  • Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
  • 30 country-specific toll-free numbers.
News and updates

The latest

4 statistics that showcase the broad impact of laboratory medicine

Medical Laboratory Professionals Week is a time to appreciate the profound impact of laboratory medicine on healthcare and innovation.

Learn more
Spotlighting the importance of cultivating the hospital laboratory

In recent articles, Mayo Clinic Laboratories emphasizes the transformative potential of recognizing and leveraging the capabilities of a hospital laboratory. With more touchpoints than any other outpatient service line, the laboratory is full of opportunity to enhance local healthcare delivery and bolster a hospital’s financial stability.

Targeted panel boosts accuracy of hereditary pancreatitis testing: Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C.

Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C., explain how Mayo Clinic Laboratories' targeted test panel facilitates accurate diagnosis of hereditary pancreatitis, which heightens the risk for pancreatic cancer. Test results can guide cancer monitoring for patients and their families.

Mayo Clinic Laboratory and Pathology Research Roundup: March 26

This week's research roundup feature: Implant-associated infections (IAIs) pose serious threats to patients and can be associated with significant morbidity and mortality. These infections may be difficult to diagnose due, in part, to biofilm formation on device surfaces, and because even when microbes are found, their clinical significance may be unclear. Despite recent advances in laboratory testing, IAIs remain a diagnostic challenge.

Technology Needs and Challenges in the Outreach Lab

In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, speaks with Dan Nelson, a Mayo Clinic contract employee and laboratory connectivity expert. They discuss the unique needs and challenges that outreach labs face with information technology (IT) systems.

Visit Mayo Clinic Laboratories at the American Academy of Neurology Annual Meeting 2024

Join Mayo Clinic Laboratories at the American Academy of Neurology Annual Meeting 2024.

Industry Updates From the Nation’s Capital: Bill Morice, M.D., Ph.D.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss important industry updates and legislative insights gathered from Dr. Morice’s recent trip to Washington, D.C.

Dr. Morice details how hospitals can maximize the value of their labs

William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, is a contributing author on Nasdaq.com. In his latest article, he describes the untapped potential of hospital laboratories and how health systems can maximize the value of their labs.

Mayo Clinic Labs @Work: Carrie Lahner

Carrie began her career at Mayo Clinic in 2006 as the associate director of the Eisenberg Genomics Education Program. In her current role as a genetic counselor, she employs her skills to educate on genetic test offerings and support MCL’s product management team. Motivated by her family’s experience with a genetic condition, Carrie finds purpose and passion in sparking conversations and fostering understanding about the benefits of genetic testing, striving to make genomics accessible to diverse audiences.

Test identifies Lynch syndrome for targeted cancer monitoring: Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC

Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC, explain how Mayo Clinic Laboratories' gene panel establishes a diagnosis of Lynch syndrome, which heightens the risk for several cancers. Test results can guide targeted cancer surveillance for patients and their families.

Mayo Clinic Laboratory and Pathology Research Roundup: March 19

This week's research roundup feature: The revised 4th edition of the World Health Organization (WHO4R) classification lists myelodysplastic syndromes with ring sideroblasts (MDS-RS) as a separate entity with single lineage (MDS-RS-SLD) or multilineage (MDS-RS-MLD) dysplasia. The more recent International Consensus Classification (ICC) distinguishes between MDS with SF3B1 mutation (MDS-SF3B1) and MDS-RS without SF3B1 mutation; the latter is instead included under the category of MDS not otherwise specified. The current study includes 170 Mayo Clinic patients with WHO4R-defined MDS-RS, including MDS-RS-SLD (N=83) and MDS-RS-MLD (N=87); a subset of 145 patients were also evaluable for the presence of SF3B1 and other mutations, including 126 with (87%) and 19 (13%) without SF3B1 mutation.

The seven S’s of connectivity impact

With many organizations using a digital-first approach, it is easy to assume that is always the best option. But is it? And what about for your laboratory outreach program? Laboratories should consider these seven S’s when deciding whether connectivity will align with the goals of their outreach programs.

The Bullet Catch and Other Deadly Illusions!

In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with Reade Quinton, M.D., assistant professor of laboratory medicine and pathology, to discuss[...]

View More
INTERESTED IN LEARNING MORE?

Fill out the form below and one of our specialists will be in touch.

Are you a patient? Click here.

(BETA) Choose a language to view this content in:
About the translation.